InsidersTradesSigma
Total declarations
Companies
▲ Purchases (29 ops.)
▼ Sales (22 ops.)
Browse the full record of transactions filed by PERCEPTIVE ADVISORS LLC, Managing Member / Founder and CEO. Insider active across 14 companies, notably Aldeyra Therapeutics, Inc.. Cumulatively, 55 reports have been published. Total volume traded: €223.6m. The latest transaction was filed on 29 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations55 total
€772,788270,000 shares@ €2.8622100.0% of flow
Common Stock
SEC:0001062993-22-015719:0·
Ideal exit: 26 Mar 2023 (T+270)
€201,22169,000 shares@ €2.91630.11% mcap0.3% of flow
American Depositary Shares
SEC:0001062993-22-013616:0·
Ideal exit: 20 Feb 2023 (T+270)
€20,2808,700 shares@ €2.3310.011% mcap0.0% of flow
American Depositary Shares
SEC:0001062993-22-013535:0·
Ideal exit: 17 Feb 2023 (T+270)
€3m157,515 shares@ €20.60880.073% mcap7.3% of flow
Common Stock
SEC:0001062993-22-010385:0·
Ideal exit: 13 Jan 2023 (T+270)
€23m5,924,170 shares@ €3.898100.0% of flow
Common Stock
SEC:0001062993-22-010256:0·
Ideal exit: 7 Jan 2023 (T+270)
€950,650200,000 shares@ €4.753294.2% of flow
Common Stock
SEC:0000899243-21-047751·
Ideal exit: 4 Sept 2022 (T+270)
€950,650200,000 shares@ €4.75320.39% mcap47.1% of flow
Common Stock
SEC:0000899243-21-047751:0·
Ideal exit: 4 Sept 2022 (T+270)
€8m2,707,463 shares@ €2.921460.3% of flow
Common Stock
SEC:0001062993-21-012195·
€8m2,707,463 shares@ €2.921430.1% of flow
Common Stock
SEC:0001062993-21-012195:0·
€31m2,250,000 shares@ €13.817695.1% of flow
Ordinary Shares
SEC:0001062993-21-010295·
Ideal exit: 31 Jul 2022 (T+270)
€31m2,250,000 shares@ €13.817617.50% mcap47.4% of flow
Ordinary Shares
SEC:0001062993-21-010295:0·
Ideal exit: 31 Jul 2022 (T+270)
€2m120,000 shares@ €13.41224.9% of flow
Ordinary Shares
SEC:0000899243-21-042807·
Ideal exit: 29 Jul 2022 (T+270)
€2m120,000 shares@ €13.41220.91% mcap2.5% of flow
Ordinary Shares
SEC:0000899243-21-042807:0·
Ideal exit: 29 Jul 2022 (T+270)
€20m1,200,000 shares@ €17.05180.46% mcap100.0% of flow
Common Stock
SEC:0000899243-21-041399·
Ideal exit: 22 Jul 2022 (T+270)
€20m1,200,000 shares@ €17.05180.46% mcap46.3% of flow
Common Stock
SEC:0000899243-21-041399:0·
Ideal exit: 22 Jul 2022 (T+270)
€4m5,734,560 shares@ €0.7328100.0% of flow
Common Stock
SEC:0001062993-21-009586·
Ideal exit: 10 Jul 2022 (T+270)
€4m5,734,560 shares@ €0.732850.0% of flow
Common Stock
SEC:0001062993-21-009586:0·
Ideal exit: 10 Jul 2022 (T+270)
2,704,587 shares
Common Stock
SEC:0001062993-21-009543·
2,704,587 shares
Common Stock
SEC:0001062993-21-009543:0·
€167,48913,082 shares@ €12.803100.0% of flow
Common Stock
SEC:0001062993-21-009486·
€167,48913,082 shares@ €12.8031.18% mcap50.0% of flow
Common Stock
SEC:0001062993-21-009486:0·
€42,38840,603 shares@ €1.0440.0022% mcap2.0% of flow
Common Stock
SEC:0001062993-21-009017·
€42,38840,603 shares@ €1.0440.0022% mcap1.0% of flow
Common Stock
SEC:0001062993-21-009017:0·
€268,308250,000 shares@ €1.07320.014% mcap12.4% of flow
Common Stock
SEC:0001062993-21-009000·
€268,308250,000 shares@ €1.07320.014% mcap6.2% of flow
Common Stock
SEC:0001062993-21-009000:0·
25 of 55 declarations
About PERCEPTIVE ADVISORS LLC
Perceptive Advisors LLC is a life-sciences-focused investment firm founded in 1999. Its founder, Joseph Edelman, serves as the firm’s managing member, and SEC filings consistently identify him as the person controlling and representing the advisor in its investment vehicles. Perceptive’s own materials also describe Edelman as Chief Executive Officer & Portfolio Manager, underscoring his leadership across the firm’s healthcare investing activities. ([perceptivelife.com](https://www.perceptivelife.com/about?utm_source=openai))
